"10.1371_journal.pone.0135327","plos one","2015-08-24T00:00:00Z","Cheryl Barnabe; Ye Sun; Gilles Boire; Carol A Hitchon; Boulos Haraoui; J Carter Thorne; Diane Tin; Désirée van der Heijde; Jeffrey R Curtis; Shahin Jamal; Janet E Pope; Edward C Keystone; Susan Bartlett; Vivian P Bykerk; CATCH Investigators","Department of Medicine and Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Universite de Sherbrooke, Sherbrooke, Quebec, Canada; Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Rheumatic Disease Unit, Institut de Rheumatologie, Montreal, Quebec, Canada; Southlake Regional Health Centre, Newmarket, Ontario, Canada; Leiden University Medical Centre, Leiden, The Netherlands; University of Alabama at Birmingham, Birmingham, Alabama, United States of America; University of British Columbia, Vancouver, British Columbia, Canada; Western University, London, Ontario, Canada; McGill University, Montreal, Quebec, Canada; Hospital for Special Surgery, Weill Cornell Medical College, New York, New York, United States of America","Conceived and designed the experiments: VPB YS CB GB CAH BH JCT DvdH SJ JEP ECK SB. Analyzed the data: YS CB VPB. Contributed reagents/materials/analysis tools: CB GB CAH BH JCT DvdH SJ JEP ECK VPB. Wrote the paper: CB YS GB CAH BH JCT DT DvdH JRC SJ JEP ECK SB VPB.","The CATCH study was designed and implemented by the investigators and financially supported initially by Amgen Canada Inc. and Pfizer Canada Inc. via an unrestricted research grant since inception of CATCH. As of 2011, further support was provided by Hoffmann-La Roche Ltd., United Chemicals of Belgium (UCB) Canada Inc., Bristol-Myers Squibb Canada Co., Abbott Laboratories Ltd., and Janssen Biotech Inc. (a wholly owned subsidiary of Johnson & Johnson Inc.). Cheryl Barnabe received advisory board honoraria from the following commercial sources: Amgen Canada Inc. and Pfizer Canada Inc. Hoffmann-La Roche Ltd., United Chemicals of Belgium (UCB) Canada Inc., Bristol-Myers Squibb Canada Co., Abbott Laboratories Ltd., and Janssen Biotech Inc. (a wholly owned subsidiary of Johnson & Johnson Inc.). There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","08","Cheryl Barnabe","CB",15,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
